EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Endocrinology

• Publication date

  2008-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.2008-0408PMID 18719023
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Skp2 suppresses p53-dependent apoptosis by inhibiting p300.

  2008cited by this paper
• The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.

  2008cited by this paper
• Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer

  2008cited by this paper
• Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen.

  2007cited by this paper
• Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

  2007cited by this paper
• Renal damage in obstructive nephropathy is decreased in Skp2-deficient mice.

  2007cited by this paper
• Hormonal induction of adipogenesis induces Skp2 expression through PI3K and MAPK pathways

  2007cited by this paper
• Pentagalloylglucose inhibits estrogen receptor α by lysosome‐dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF‐7 cells

  2006cited by this paper
• Prognostic impact of Skp2 and p27 in human breast cancer

  2006cited by this paper
• The combination of green tea and tamoxifen is effective against breast cancer.

  2006cited by this paper
• Metastatic breast cancer: an updating.

  2006cited by this paper
• The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells

  2006cited by this paper
• Significance of skp2 expression in primary breast cancer.

  2006cited by this paper
• Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.

  2006cited by this paper
• Green tea and the prevention of breast cancer: a case-control study in Southeast China.

  2006cited by this paper
• Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer

  2006cited by this paper
• Downregulation of Skp2 and p27/Kip1 synergistically induces apoptosis in T98G glioblastoma cells

  2005cited by this paper
• Clinical trials of intracellular signal transductions inhibitors for breast cancer--a strategy to overcome endocrine resistance.

  2005cited by this paper
• Growth of LNCaP cells in monoculture and coculture with osteoblasts and response to tNOX inhibitors.

  2005cited by this paper
• The expression of the ubiquitin ligase subunit Cks1 in human breast cancer

  2005cited by this paper
• Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

  2005cited by this paper
• Relationship between levels of Skp2 and P27 in breast carcinomas and possible role of Skp2 as targeted therapy.

  2005cited by this paper
• Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation.

  2005cited by this paper
• Control of the SCFSkp2–Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase

  2004cited by this paper
• Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.

  2004cited by this paper
• Elevated polyamines lead to selective induction of apoptosis and inhibition of tumorigenesis by (-)-epigallocatechin-3-gallate (EGCG) in ODC/Ras transgenic mice.

  2004cited by this paper
• Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C(Cdh1) ubiquitin ligase.

  2004cited by this paper
• Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells

  2004cited by this paper
• Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex

  2004cited by this paper
• Estrogens Down-regulate p27Kip1 in Breast Cancer Cells through Skp2 and through Nuclear Export Mediated by the ERK Pathway*

  2003cited by this paper
• Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer

  2003cited by this paper
• Therapeutic anti-cancer targets upstream of the proteasome.

  2003cited by this paper
• Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells.

  2003cited by this paper
• Down‐regulation of SKP2 induces apoptosis in lung‐cancer cells

  2003cited by this paper
• Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.

  2003cited by this paper
• Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.

  2002cited by this paper
• Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival.

  2002cited by this paper
• Expression of Skp2, a p27(Kip1) ubiquitin ligase, in malignant lymphoma: correlation with p27(Kip1) and proliferation index.

  2002cited by this paper
• PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest

  2002cited by this paper
• Estrogen receptor-mediated actions of polyphenolic catechins in vivo and in vitro.

  2002cited by this paper
• Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.

  2002cited by this paper
• Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone‐treated MCF‐7 breast cancer cells

  2002cited by this paper
• Multifaceted Regulation of Cell Cycle Progression by Estrogen: Regulation of Cdk Inhibitors and Cdc25A Independent of Cyclin D1-Cdk4 Function

  2001cited by this paper
• Skp2 is oncogenic and overexpressed in human cancers

  2001cited by this paper
• Role of the F-box protein Skp2 in lymphomagenesis

  2001cited by this paper
• A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase

  2001cited by this paper
• Degradation of p27 Kip1 at the G0-G1 Transition Mediated by a Skp2-independent Ubiquitination Pathway*

  2001cited by this paper
• Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas

  2001cited by this paper
• Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication

  2000cited by this paper
• Effects of tea catechins on the ERE-regulated estrogenic activity.

  2000cited by this paper
• Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.

  2000cited by this paper
• Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.

  1999cited by this paper
• SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27

  1999cited by this paper
• Inhibition of cyclin‐dependent kinases 2 and 4 activities as well as induction of cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (−)‐epigallocatechin‐3‐gallate

  1999cited by this paper
• Influence of Drinking Green Tea on Breast Cancer Malignancy among Japanese Patients

  1998cited by this paper
• Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols.

  1998cited by this paper
• Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer

  1997cited by this paper
• Estrogen-induced Activation of Cdk4 and Cdk2 during G1-S Phase Progression Is Accompanied by Increased Cyclin D1 Expression and Decreased Cyclin-dependent Kinase Inhibitor Association with Cyclin E-Cdk2*

  1997cited by this paper
• The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.

  1997cited by this paper
• Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells.

  1996cited by this paper
• Growth inhibition and regression of human prostate and breast tumors in athymic mice by tea epigallocatechin gallate.

  1995cited by this paper
• Tea and cancer.

  1993cited by this paper
• A large scale cohort study on cancer risks by diet--with special reference to the risk reducing effects of green-yellow vegetable consumption.

  1985cited by this paper
• The role of progestins and progesterone receptors in the treatment of breast cancer.

  1984cited by this paper
• Polypharmacy in psychiatry: a multi-state comparison of psychotropic drug combinations.

  1974cited by this paper

• A rapid imaging-based screen for induced-proximity degraders identifies a potent degrader of oncoprotein SKP2.

  2025cites this paper
• Green tea EGCG inhibits naïve CD4+ T cell division and progression in mice: An integration of network pharmacology, molecular docking and experimental validation

  2023cites this paper
• The crosstalk between ubiquitination and endocrine therapy

  2023cites this paper
• Progress in Anticancer Drug Development Targeting Ubiquitination-Related Factors

  2022cites this paper
• The FBXW7‐NOTCH interactome: A ubiquitin proteasomal system‐induced crosstalk modulating oncogenic transformation in human tissues

  2021cites this paper
• Curcumin and Carnosic Acid Cooperate to Inhibit Proliferation and Alter Mitochondrial Function of Metastatic Prostate Cancer Cells

  2021cites this paper
• Emerging Roles of SKP2 in Cancer Drug Resistance

  2021cites this paper
• Estrogenic biological activity and underlying molecular mechanisms of green tea constituents

  2020cites this paper
• Protective Effects of Epigallocatechin Gallate (EGCG) on Endometrial, Breast, and Ovarian Cancers

  2020influential citation
• F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects

  2020cites this paper
• Targeting SCF E3 Ligases for Cancer Therapies.

  2020cites this paper
• The Skp2 Pathway: A Critical Target for Cancer Therapy.

  2020cites this paper
• PTEN is involved in Kanglaite ® injection-induced apoptosis of human pancreatic cancer cells

  2019cites this paper
• A patent review of the ubiquitin ligase system: 2015–2018

  2018cites this paper
• The establishment of cell suspension culture of sabah snake grass (Clinacanthus nutans (Burm.F.) Lindau)

  2018cites this paper
• Dysregulated expression of SKP2 and its role in hematological malignancies

  2018cites this paper
• Cancer and Chemoprevention: An Overview

  2017cites this paper
• Chemoprevention by Epigallocatechin-3-Gallate (EGCG)

  2017cites this paper
• S-phase kinase-associated protein 2 promotes cell growth and motility in osteosarcoma cells

  2017cites this paper
• UPDATES AND ADDITIONS for Herbal Contraindications &Drug Interactions plus Herbal Adjuncts with Medicines

  2016cites this paper
• Recent advances in SCF ubiquitin ligase complex: Clinical implications.

  2016cites this paper
• Protective role of epigallocatechin-3-gallate in health and disease: A perspective.

  2016cites this paper
• Dietary phytochemicals as epigenetic modifiers in cancer: Promise and challenges.

  2016cites this paper
• Curcumin inhibits cell growth and invasion and induces apoptosis through down-regulation of Skp2 in pancreatic cancer cells.

  2016cites this paper
• Small molecule therapeutics targeting F-box proteins in cancer.

  2016cites this paper
• F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.

  2016cites this paper
• Green tea phytocompounds as anticancer: A review

  2016cites this paper
• Green Tea and Anticancer Perspectives: Updates from Last Decade

  2015cites this paper
• Targeting the ubiquitin pathway for cancer treatment.

  2015cites this paper
• Arsenic Trioxide Inhibits Cell Growth and Invasion via Down- Regulation of Skp2 in Pancreatic Cancer Cells.

  2015cites this paper
• The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway

  2014cites this paper
• Antitumor effect of Kanglaite® injection in human pancreatic cancer xenografts

  2014cites this paper
• Acquisition of epithelial–mesenchymal transition is associated with Skp2 expression in paclitaxel-resistant breast cancer cells

  2014cites this paper
• Effect of green tea catechins on breast carcinogenesis: a systematic review of in-vitro and in-vivo experimental studies

  2014cites this paper
• Epigallocatechin 3-O-gallate induces 67 kDa laminin receptor-mediated cell death accompanied by downregulation of ErbB proteins and altered lipid raft clustering in mammary and epidermoid carcinoma cells.

  2014cites this paper
• SKP2 Overexpression Is Associated With Increased Serine 10 Phosphorylation of p27 (pSer10p27) in Triple‐Negative Breast Cancer

  2014cites this paper
• In Vitro and In Vivo Effects of Jia-Wei-Xiao-Yao-San in Human Breast Cancer MCF-7 Cells Treated With Tamoxifen

  2014cites this paper
• Interaction of Green Tea Catechins with Breast Cancer Endocrine Treatment: A Systematic Review

  2014cites this paper
• In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab

  2013cites this paper
• Effect of Green Tea Catechins on Intracellular Signaling in Breast Tissue: Implications for Cancer

  2013cites this paper
• Regulation and action of SKP2 and RhoA in cell and tumor models: Investigation into the molecular mechanisms responsible for the aggressive phenotype of triple-negative breast cancer

  2013cites this paper
• PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells.

  2013cites this paper
• Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil

  2013cites this paper
• Oncogenic role of Skp2 and p27Kip1 in intraductal proliferative lesions of the breast.

  2012cites this paper
• Skp2: a novel potential therapeutic target for prostate cancer.

  2012cites this paper
• Prodigiosin down‐regulates SKP2 to induce p27KIP1 stabilization and antiproliferation in human lung adenocarcinoma cells

  2012cites this paper
• Oncogenic role of Skp2 and p27Kip1 in intraductal proliferative lesions of the breast.

  2012cites this paper
• 1,2,3,4,6-penta-O-galloyl-β-D-glucose, quercetin, curcumin and lycopene induce cell-cycle arrest in MDA-MB-231 and BT474 cells through downregulation of Skp2 protein.

  2011cites this paper
• Skp2 is a Promising Therapeutic Target in Breast Cancer

  2011influential citation
• Cancer chemoprevention by dietary polyphenols: promising role for epigenetics.

  2010cites this paper
• p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.

  2009cites this paper
• Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.

  2009cites this paper